Case Reports
doi: 10.1016/j.transproceed.2008.09.050.
"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report
Affiliations
- PMID: 19100497
- DOI: 10.1016/j.transproceed.2008.09.050
Item in Clipboard
Case Reports
"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report
Transplant Proc.
2008 Dec.
Abstract
Fibrolamellar (FL) hepatocellular carcinoma (HCC) is a distinctive form of primary HCC that occurs principally in children and young adults. Although liver transplantation is not contraindicated for FL-HCC, noncirrhotic patients with large HCC tumors (including FL-HCCs) are not prioritized. Although hepatic resection is considered to be the primary treatment for FL-HCC, living donor liver transplantation is evolving into a potentially better alternative. Herein we have reported successful "preemptive" living donor liver transplantation for presumed recurrence of FL-HCC after an extended right hepatectomy with resection and synthetic graft replacement of the inferior vena cava.
Similar articles
-
Aggressive combined resection of hepatic inferior vena cava, with replacement by a ringed expanded polytetrafluoroethylene graft, in living-donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.J Hepatobiliary Pancreat Sci. 2010 Sep;17(5):719-24. doi: 10.1007/s00534-010-0287-z. Epub 2010 Apr 28. J Hepatobiliary Pancreat Sci. 2010. PMID: 20425126
-
Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava.Liver Transpl. 2004 Apr;10(4):555-6. doi: 10.1002/lt.20132. Liver Transpl. 2004. PMID: 15048801
-
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.Eur J Cancer. 2013 Aug;49(12):2698-704. doi: 10.1016/j.ejca.2013.04.012. Epub 2013 May 15. Eur J Cancer. 2013. PMID: 23683550
-
Surgical resection and liver transplantation for hepatocellular carcinoma.Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2. Clin Liver Dis. 2015. PMID: 25921669 Review.
-
[Liver resection and liver transplantation in liver cell adenoma, hepatocellular carcinoma and fibrolamellar liver carcinoma].Praxis (Bern 1994). 2001 Jan 11;90(1-2):7-13. Praxis (Bern 1994). 2001. PMID: 11206098 Review. German.
Cited by
-
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.Organogenesis. 2014 Apr-Jun;10(2):241-9. doi: 10.4161/org.29245. Epub 2014 May 16. Organogenesis. 2014. PMID: 24836922 Free PMC article. Review.
-
Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.Surg Today. 2017 Apr;47(4):403-415. doi: 10.1007/s00595-016-1337-1. Epub 2016 Apr 29. Surg Today. 2017. PMID: 27130463 Review.
-
Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells.Oncogene. 2016 Jan 7;35(1):116-24. doi: 10.1038/onc.2015.67. Epub 2015 Mar 16. Oncogene. 2016. PMID: 25772244
-
New and old technologies for organ replacement.Curr Opin Organ Transplant. 2013 Apr;18(2):179-85. doi: 10.1097/MOT.0b013e32835f0887. Curr Opin Organ Transplant. 2013. PMID: 23449347 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
